Business
Aeterna Zentaris to Present at Upcoming Canaccord Genuity 35th Annual Global Growth Conference in Boston
QUÉBEC CITY, Aug. 4, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX:&#...
About this update from Cosciens Biopharma Inc.
[{"type":"text","content":"\n\nQUÉBEC CITY, Aug. 4, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the \"Company\") today announced that the Company's Chairman and CEO, David Dodd, will be presenting a corporate overview at the Canaccord Genuity 35th Annual Global Growth Conference on Wednesday, August 12, 2015, at 11 am (Eastern), in the Melbourne Room of the Intercontinental Hotel in Boston.\n\nA live audio and slide webcast of the presentation will be available via the Company's website at www.aezsinc.com in the \"Newsroom\" section, under \"Events and Webcasts\". A replay of the webcast will also be available on the Company's website for a period of 90 days.\n\nAbout Aeterna Zentaris Inc.\n\nAeterna Zentaris is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. For more information, visit www.aezsinc.com.\n\n \nSOURCE Aeterna Zentaris Inc.\n\n\n\nPaul Burroughs, Director of Communications, (418) 652-8525 ext. 406, [email protected] CNW Group 2015","length":1737,"tagName":"div"}]